Y-mAbs Therapeutics, Inc.·4

Aug 30, 4:15 PM ET

Lund-Hansen Torben 4

4 · Y-mAbs Therapeutics, Inc. · Filed Aug 30, 2024

Insider Transaction Report

Form 4
Period: 2024-08-28
Lund-Hansen Torben
Sr VP & Head of Technical Oper
Transactions
  • Sale

    Common Stock

    2024-08-28$15.37/sh50,000$768,50035,600 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2024-08-2850,000100,000 total
    Exercise: $4.38Exp: 2026-05-20Common Stock (50,000 underlying)
  • Exercise/Conversion

    Common Stock

    2024-08-28$4.38/sh+50,000$219,00085,600 total
Holdings
  • Common Stock

    (indirect: By Toluha ApS)
    45,662
Footnotes (3)
  • [F1]This transaction was executed in multiple trades at prices ranging from $15.00 to $15.6978, inclusive. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F2]Reporting Person is sole member of Toluha ApS.
  • [F3]Stock options are fully vested.

Documents

1 file
  • 4
    form4-08302024_040801.xmlPrimary